key: cord-0258316-bvlz95vo
authors: Ozantürk, Ayşe N.; Sahu, Sanjaya K.; Kulkarni, Devesha H.; Ma, Lina; Barve, Ruteja A; McPhatter, Ja’Nia; Garnica, Lorena; Dannull, Linus; Kunen, Jeremy; Wu, Xiaobo; Brody, Steven L.; Atkinson, John P.; Kulkarni, Hrishikesh S.
title: Lung epithelial cell-derived C3 protects against pneumonia-induced lung injury
date: 2022-02-05
journal: bioRxiv
DOI: 10.1101/2022.02.03.478963
sha: 38fdea3879343131c1094d3e3c31aa9761a5b372
doc_id: 258316
cord_uid: bvlz95vo

The complement component C3 is a fundamental plasma protein for host defense. However, recent work has demonstrated the critical importance of local C3 expression in cell survival. Here we analyzed the effects of local versus peripheral sources of C3 expression in a model of bacterial pneumonia. While mice with global C3 deficiency had severe pneumonia-induced lung injury, those deficient in liver-deficient C3 remain protected, comparable to wildtype mice. Human lung transcriptome analysis showed secretory epithelial cells are a major source of C3. Mice with a C3 gene ablation from lung epithelial cells had worse pulmonary injury compared to wild type, despite maintaining normal circulating C3 levels. Finally, in human cellular and mouse pneumonia models, we show that C3 reduces epithelial cell death mediated through the alternative pathway component Factor B. Thus, our findings suggest that a locally-derived C3-Factor B pathway protects the lung mucosal barrier. One Sentence Summary Lung-derived C3 mitigates severe bacterial pneumonia suggesting a novel cytoprotective role at mucosal barrier surfaces independent of circulating C3.

Pathogens infect and injure mucosal surfaces resulting in a cascade of events including inflammation, tissue damage and systemic dissemination (1, 2) . In the lung, this process results in severe pneumonia, a leading cause of death, even before the SARS-CoV-2 pandemic (3, 4) .

The outcome in pneumonia is determined by a balance between immune resistance and tissue resilience of the host (1, 5) . Immune resistance is the host's ability to eradicate pathogens, whereas tissue resilience is the ability of the lung to withstand the deleterious consequences of infection and inflammation (1, 5) . The complement system is a family of immune proteins that facilitate immune resistance by attacking microbes to decrease pathogen burden (6, 7) .

Consequently, genetic and acquired deficiencies of complement characteristically lead to recurrent bacterial infections in both children and adults (8, 9) . However, there has been an increasing appreciation recently of how the system functions to promote tissue resilience in the setting of acute infections (10, 11) .

A majority of the complement proteins are primarily liver-derived (12) . One such protein, C3, is a central component of the complement system, as multiple pathways converge on its activation to C3a and C3b, thereby amplifying the cascade (13) . The plasma concentration of C3 is approximately 1-2 mg/ml in humans, resulting it in being one of the most common proteins in the circulation after other liver-derived proteins such as albumin and α -2-macroglobulin (14) .

Thus, the protective effects of C3 have largely been attributed to it being sourced from the liver and present in a high concentration in the circulation. However, we and others have previously demonstrated that C3 is also produced outside of the liver by multiple immune and non-immune cell populations (15) (16) (17) (18) (19) . This observation has implications, especially for organs that constantly interact with pathogens and environmental toxins, such as the mucosal surface of the lung (6, 20) . For example, we have demonstrated that C3 synthesized as well as internalized by lung epithelial cells protects against stress-induced cell death (16, 21) . Others have demonstrated that chronic C3 upregulation in lung epithelial cells can perpetuate inflammation in SARS-CoV-2 infection (19) .

It is unknown whether cell-intrinsic C3 production is relevant in vivo. It is also unclear if the protective effects of C3 are purely a result of enhancing immune resistance via its bactericidal activity, or it also contributes to tissue resilience by reducing acute lung injury (ALI). To address these questions, we utilized a model of acute Pseudomonas aeruginosa (Pa) pneumonia in mice globally deficient in C3 and report that C3 not only promotes immune resistance but also enhances tissue resilience in vivo by mitigating ALI. Using publicly available human lung datasets and a C3 reporter mouse model, we establish that multiple structural cell types in the lung produce and upregulate C3 in the setting of Pa infection. Building on these findings, we generated novel mouse strains and show that lung-derived C3 is functioning locally, independent of circulating (i.e., liver-derived) C3 and is necessary for reducing Pa-induced ALI. Using both human in vitro and mouse in vivo infection models, we show that cell-intrinsic Factor B -a component of the alternative pathway and a ligand for C3 -is a key component of tissue resilience, enhancing the ability of the lung to withstand the deleterious consequences of infection and inflammation. Our findings potentially refine the approach for therapeutically targeting the complement system in the lung with the goal of mitigating bacterial pneumonia severity.

given either immediately after the Pa infection, and the mice were followed for 24 h prior to euthanasia, or it was given 1 h prior to euthanasia, by the time the injury had already occurred.

Splenic bacterial dissemination was lower in mice administered NMS compared to C3-deficient serum (Fig S2A) . C3 was detected in the BAL at 24 h after NMS administration only in the C3deficient mice administered NMS who had alveolar-capillary barrier disruption in the setting of Pa pneumonia, not in those who had only received intratracheal PBS. (Fig 2C) . However, C3

was not detected in the BAL at 1 h post NMS administration even if the lungs had been injured by Pa, despite being detected in the circulation. These observations suggest that following disruption of the alveolar-capillary barrier, circulating C3 entry into the alveolar space is delayed relative to local C3 secretion.

To quantify C3 expression and production by different cell types, we utilized C3 reporter mice with an IRES (internal ribosome entry side)-tdTomato cassette after the stop signal in the endogenous murine C3 locus, and also has the exons 37-41 sequence flanked by loxP sites enabling its conditional deletion upon the action of a Cre recombinase (15) . Given that the liver is the major source of circulating C3, we bred these mice to generate an in vivo model of C3 deficiency restricted to the liver (C3 f/f ; Alb-Cre +/-) (Fig 2D) . We confirmed these mice had no expression of C3 in the liver (Fig 2E) and had undetectable levels of circulating C3 compared to littermate controls and WT mice both pre and post Pa (Fig 2F) . However, C3 was detectable (albeit in smaller amounts compared to littermate controls) in the BAL of infected mice at 24 h (Fig 2G) .

Although there was no functional complement activity in the circulation of the C3 f/f ; Alb-Cre +/mice as compared to their littermate controls prior to infection (Fig 2H) , BAL from C3 f/f ; Alb-Cre +/mice was still functional (Fig 2I) . Post-infection, there was no increase in the functional complement activity in the circulation of the C3 f/f ; Alb-Cre +/mice as compared to pre-infection levels (Fig 2H) . In comparison, the functional activity of the BAL increased at 24 h postinfection in the C3 f/f ; Alb-Cre +/mice (Fig 2I) . Taken together, these observations suggest that although circulating C3 is functional in the lung in the setting of an acute infection, sources of C3 other than the liver also contribute to the C3 function in the lung.

Given the lack of both detectable circulating C3 in the C3 f/f ; Alb-Cre +/mice nor any functional complement activity in the serum, we hypothesized that the functional complement activity in the BAL of the C3 f/f ; Alb-Cre +/mice was generated from the lung. The presence of a thoroughly functional extra-hepatic source of C3 was corroborated by lower splenic dissemination of bacteria in the C3 f/f ; Alb-Cre +/mice as compared to the global C3-deficient mice, but higher in these mice compared to their littermate controls (Fig 2J) . These findings would suggest that although liver-derived C3 is necessary for limiting bacterial dissemination, sources of C3 other than those from the liver also have an important role. Moreover, there was no difference in either the lung wet-dry ratio (Fig 2K) , the BAL cell count (Fig 2L) or histological evidence of injury ( Fig S2B) in mice deficient in liver-derived C3 as compared to their littermate controls at 24 h post-Pa infection, although it was reduced when compared to global C3-deficient mice. These observations suggest lung-derived C3 played a key role in mitigating bacterial pneumoniainduced lung injury. No differences were observed in BAL cytokine levels in mice deficient in liver-derived C3 as compared to their littermate controls at 24 h post-Pa infection (Fig S2C-F) .

To evaluate sources of C3 in the normal human lung, we analyzed publicly available single-cell RNASeq datasets from the Lung Gene Expression Atlas and LungMAP (27) (28) (29) (30) . Our analysis showed that, although most cells expressed C3 transcripts, major sources of C3 in the lungs are epithelial cells, fibroblasts and, to a lesser extent, monocytes/macrophages (Fig 3A and S3A ).

To identify cell-intrinsic production of C3 in the lungs in the absence of circulating C3, we profiled C3 producing non-immune cells in liver-deficient C3 mice (C3 f/f ; Alb-Cre +/-) infected with Pa, who have an IRES-Td tomato cassette after the stop signal in the endogenous murine C3 locus (C3 expression reporter mice). In these mice, C3 increased by approximately 3-fold in airway epithelial cells and Type 1 alveolar epithelial cells, and increased by nearly 4-fold from baseline in Type 2 alveolar epithelial cells, fibroblasts and endothelial cells at 24 h post-Pa infection (Fig 3B and S3B) . We had previously shown that lung epithelial cells expressing SCGB1A1 (i.e., CCSP) are a major source of C3 in humans, especially in diseases associated with recurrent infections such as cystic fibrosis (16) , and we were interested in how C3 from cells at the mucosal barrier surface affect the host response to pneumonia. Hence, we generated C3 f/f ; Scgb1a1-CreER T2+/mice to specifically delete C3 produced by these epithelial cells (club cell deficient-C3 mice); hereafter, termed as mice deficient in 'lung-derived C3' (Fig 3C and   S3C ). Successful deletion of C3 from club cells was confirmed using immunofluorescence for C3 and Cyp2f2, a club cell marker (Fig 3D) (31) . These mice deficient in lung-derived C3 had similar levels of C3 in their circulation and BAL as their littermate controls (Fig 3E and 3F) .

They also had similar serum and BAL functional complement activity compared to their littermate controls (Fig 3G and 3H ).

C3 f/f ; Scgb1a1-CreER T2+/mice had worse acute lung injury after Pa infection compared to their littermate controls, as represented by measures of alveolar-capillary barrier disruption (Fig 4A   and 4B) . They also had worse histology (Fig 4C) and an exaggerated inflammatory response as compared to their littermate controls, as measured by BAL cytokine levels of IL-1β, IL-6, KC and TNF-α (Fig 4D-G) . Despite there being no significant differences in the systemic bacterial dissemination (Fig 4H) , there was increased epithelial cell injury in these mice deficient in lungderived C3 compared to their littermate controls, as measured by a marked increase in BAL RAGE levels (Fig 4I) , as well as increased epithelial cell death, as measured by an increase in BAL cytokeratin-18 (CK-18) levels ( Fig 4J) .(32) These findings suggest that lung-derived C3

reduces Pa-induced lung injury despite adequate circulating (i.e., liver-derived) C3 levels.

Upon activation, C3 is cleaved to form C3a, which binds to the C3a receptor (C3aR), and C3b fragments, which can opsonize targets but also bind to Factor B (FB) to form a C3 convertase (C3bBb) and amplify the alternative pathway of the complement cascade (33) . To assess which of these putative targets may be facilitating the protective effects of C3 in the lung, we infected global C3aR-deficient (C3aR -/-) and FB-deficient (Cfb -/-) mice. C3aR-deficient mice were relatively protected from Pa-induced ALI and had a pattern of injury that was similar to the WT mice (Fig 5A and 1A) . In comparison, FB-deficient mice had more severe injury (Fig 5A) .

Increased lung stiffness was observed at 24 h post-infection in FB-deficient mice compared to WT mice, as demonstrated by a worse dynamic compliance (Fig 5B) and an increased resistive index (Fig S4A) . There was increased alveolar-capillary barrier disruption post-infection as evidenced by an increased lung wet-dry ratio in FB-deficient mice compared to WT and C3aRdeficient mice (Fig 5C) . FB-deficient mice had increased inflammation post-infection, as measured by Il1b (Fig 5D) and Ccl2 (Fig S4B) expression, and increased number of Ly6C hi monocytes in the lungs of FB-deficient mice compared to WT mice (Fig S4C) . FB-deficient mice also had increased epithelial cell loss, measured by lung Scgb1a1 (Fig 5E) , Sftpc (Fig S4D) and Cdh1 (Fig S4E) expression, and increased epithelial cell death compared to WT mice as measured by BAL CK-18 levels (Fig S4F) and confirmed using amine dye exclusion on flow cytometry (Fig S4G) .

A similar pattern of increased lung injury in the setting of FB deficiency was observed in the setting of HKPa administration. FB-deficient mice had worse lung injury on histology (Fig 5F) , as well as an increased wet-dry ratio as compared to WT mice (Fig 5G) . These mice also had significantly higher expression of Il1b (Fig 5H) and Ccl2 (Fig S4H) in their lungs, which paralleled our findings in C3-deficiency. Importantly, FB-deficient mice had decreased Scgb1a1 (Fig 5I) , Sftpc (Fig S4I) and Cdh1 (Fig S4J) expression in their lungs after HKPa administration as compared to WT mice, suggesting epithelial cell loss in the setting of injury.

Given that Pa induces a bronchopneumonia, we sought to model these interactions between C3, C3aR and FB in primary human airway epithelial cells. We have previously reported that C3 increases in the primary human tracheobronchial epithelial cells (hTECs) with stress (16) . In hTECs infected with Pa, FB biosynthesis increased post-infection but the levels of C3aR remained unchanged (Fig 5J) . In line with these observations, C3 colocalized with FB in the setting of an acute Pa infection; in contrast, its colocalization with the C3aR was not observed (Fig 5K) . Hence, we subsequently sought to characterize the consequences of FB-deficiency an C3aR-deficiency in vitro in human lung epithelial cells using CRISPR-Cas9 deletion (Fig S4K   and S4L) . In an in vitro model of oxidative stress, FB-deficiency was associated with increased cell death compared to the parent clones over time (Fig S4M) . By comparison, C3aR-deficiency was protective against H 2 O 2 -induced cell death, especially within the first 24 h (Fig S4N) .

Comparing RNA sequencing (RNA-Seq) of these Pa infected FB-deficient cells with their infected FB-sufficient parental line identified cell death as a major (central) theme, utilizing COMPBIO, an ontology-free analysis approach. (www.percayAI.com) (Fig 5L) . 'Cell death' shared common biology with two other themes, ' autocrine-paracrine signaling' and 'extracellular matrix (ECM) proteoglycans' (Fig 5M) , all of which were present in the top 5 enriched themes in the analysis between FB-deficient cells and their parent clones. These three themes shared a common signature consisting of 18 genes, and their contributions towards each theme are highlighted in the pseudoheatmap (Fig 5M) . Correspondingly, FB-deficiency was associated with increased programmed cell death, evident by increased cleaved caspase-3 and cleaved PARP levels post-Pa infection (Fig 5N) and was paralleled by similar changes in the setting of oxidative stress (Fig 5O) . These findings suggest that intracellular FB facilitates lung epithelial cell survival under stress by mitigating programmed cell death.

The effects of the complement system have historically been attributed to its presence in the circulation. However, our understanding of its components being synthesized by tissues and extra-hepatic organs has evolved to recognize that cells at mucosal surfaces may have an intrinsic complement system for host defense (34) (35) (36) (37) (38) . Leveraging advances in complement biology, model systems and technologies, we demonstrate that: (1) C3 protects against acute bacterial pneumonia-induced lung injury; (2) C3 can be sourced locally, independent of that derived from the liver and present in the circulation; (3) structural cells of the lung such as epithelial cells contribute to C3 activity locally; (4) epithelial cell-derived C3 protects against severe bacterial pneumonia; and (5) this protection is potentially occurring via an intracellular complement Factor B (FB), akin to canonical complement activation that occurs extracellularly (33) , but with important physiological functions necessary for cell survival. These observations put into perspective a long-standing premise that complement -an evolutionary conserved defense system -may have originated intracellularly and evolved extracellularly with the complexity of the host (39).

Liver-derived complement proteins form a necessary component of host defense, as evidenced by recurrent infections in patients with cirrhosis (9, 40) . To that effect, we found that splenic dissemination of bacteria was significantly higher in the mice deficient in liver-derived C3 compared to controls, suggesting its role in enhancing immune resistance. However, there are two specific issues in this context that need consideration: First, that functional complement activity was observed in the bronchoalveolar lavage fluid of mice deficient in liver-derived C3 in the setting of infection, despite no activity in the circulation and, second, that splenic bacterial burden in the mice deficient in liver-derived C3 was significantly lower than that observed in global C3-deficient mice. These observations would suggest that extra-hepatic sources of C3 are induced and are important in controlling bacteremic pneumonia.

We and others have previously reported that lung epithelial cells produce and secrete C3, and this secretion is apically polarized, which may facilitate host defense at the air-liquid interface (16, 19, 41, 42) . Given our finding that C3 is upregulated in lung epithelial cells under stress in vitro, in the infected airways of people with cystic fibrosis, (16), we genetically depleted C3 specifically from lung epithelial cells that are known to be major sources of C3, Scgb1a1 + club cells (43) . The severity of bacterial pneumonia in these mice suggests that lung epithelial cellderived C3 is necessary for protection against lung injury despite adequate circulating C3 levels.

Cell-intrinsic C3 thus affects fundamental cellular processes such as survival, which until now had primarily been demonstrated in vitro (16, 17) .

C3 is cleaved to C3a and C3b upon cleavage by enzymes. C3a binds to C3aR, functions as an anaphylatoxin and also influences cellular functions such as cytokine production by T cells (44) .

C3b, on the other hand, is as an opsonin but also forms an enzyme called the "C3 convertase"

with Factor B (C3bBb) to amplify alternative pathway activation in the circulation (13, 33) . Our in vitro and in vivo findings indicating that Factor B is necessary for cellular survival, thus, aligns with the concept of an intracellular convertase that has been suggested by others (19, 45) and is now strengthened by our findings. Given that C3a-C3aR interactions have previously been shown to facilitate the differentiation of naïve CD4 + T cells towards a T H 1 phenotype (44), as well as glucose-induced insulin secretion in human and mouse pancreatic islet cells (17, 46) , our findings on cytoprotective role of Factor B suggests that intracellular C3 may have multiple targets and functions based on the stressor and the cell type. These observations therefore, create a precedent for complement modulating certain cellular processes in a stimuli-specific and cellspecific manner, and accordingly targeting therapies based on the desired effect.

There are certain limitations of our study. First, we deleted C3 from Scgb1a1 + cells based on our prior findings that (a) these cells are an abundant source of C3 (16), (b) C3 forms protects both epithelial and alveolar cells from infection (47) , and (c) Pa infection induces a bronchopneumonia (48) . Future work will need to address whether the protective effects of lungderived C3 in severe bacterial pneumonia is due to the biosynthesized C3 that is stored in cells, or is secreted by neighboring lung epithelial cells and is internalized (16, 21) . Second, there are sources of C3 in the lungs other than lung epithelial cells, such as monocyte/macrophages, fibroblasts and mesenchymal stem cells (15, (49) (50) (51) . Future studies should determine if delivering C3 to the lung via these other sources is sufficient to mitigating lung injury in a paracrine manner. Third, our current in vivo models lack the ability to detect the specific isoform of cytoprotective C3. There is an increasing acknowledgement of a secreted form of C3 that has the signal peptide versus an intracellular cytosolic form with an alternate start site downstream of the signal peptide (17) . Distinguishing these two distinct forms of C3 may have therapeutic implications if one seeks to to augment C3 within the lung. Additionally, although we have shown that C3 may be exerting its protective effect through FB (a known canonical interaction), we do not exclude non-canonical intracellular interactions, such as how C3 interacts with ATG16L1 in pancreatic β cells (17) or in gut epithelial cells, thereby targeting the intracellular bacteria towards autophagolysosomes for degradation (11) . Finally, we focused on the role of C3 in acute injury due to bacterial pneumonia (i.e., within 24 h). The effects of C3 may be different based on the stressor (19, 52, 53) and the temporal course of an infection (54) .

In summary, we show that in addition to the liver, lung-derived C3 provides host response to pneumonia by promoting both immune resistance and tissue resilience. Among these sources, epithelial-cell derived C3 mitigates severe bacterial pneumonia. This protection appears to occur via Factor B, which is an important component of the alternative pathway of the complement cascade (55) . Our observation of an intracellular Factor B protein thus adds to the growing knowledge of how intracellular complement proteins modulate fundamental processes such as cell survival (10, 11, 16, 44, 46) , and importantly, provides a putative mechanism by which lungderived C3 offers protection. An understanding of tissue-derived and intracellular complement proteins is necessary to reconcile prior trial results of complement therapeutics, a majority of which have primarily targeted circulating complement proteins and do not necessarily penetrate inside the cell (56, 57) . Thus, we are optimistic that complement therapies targeting a specific organ can be re-evaluated in terms of local protein activities, and caution against the unintentional effects of cell-permeable complement inhibitors. In this manner, we will be able to optimally harness endogenously produced immune mediators including the the complement system to better combat diseases such as pneumonia-induced lung injury.

A table following the ARRIVE guidelines for standard reporting of animal studies is included in the Supplementary Material (Table S1 ) (58) .

Research objectives. The primary objective of the research was to assess whether C3-deficiency increases the risk of severe pneumonia occurring in the setting of Pseudomonas aeruginosa infection. The secondary objectives included (i) assessing whether mice deficient in liver-derived C3, and mice deficient in lung-derived C3 were at increased risk of severe pneumonia compared to their littermate controls, and (ii) whether the protective effects of C3 occurred via C3aR and/or FB. The method for cell culture, including media composition, has been described in detail previously (16) . All cell cultures were maintained at 37 °C in 5% CO2.

C3aR-and FB-deficient BEAS-2B cells were generated by CRISPR nuclease-induced targeted double strand break at the Genome Engineering Center at WUSM. C3aR only has one coding exon; hence, the gene was knocked out by using two gRNAs to delete the whole open reading frame (Fig S4G) . CFB was disrupted by introducing out-of-frame indels in all alleles so that the mRNA would be degraded by nonsense mediated decay (Fig S4H) . These cells were confirmed to be mycoplasma-negative prior to experimentation and were compared to their parent clones in all experiments.

Experimental design. All data are reported from controlled laboratory experiments. Mice were infected with Pseudomonas aeruginosa (Pa) M57-15, a clinically relevant strain obtained from the sputum of a patient with cystic fibrosis (61) . The mice were infected with Pa for 24 h before euthanasia for blood, bronchoalveolar lavage fluid and tissue harvest. Lungs were harvested either for the wet-dry ratio, BAL collection, flow cytometry, bacterial colony counts, or as a whole organ for fixation in 10% formalin before submission for histology. Spleens were harvested for colony counts. BAL was collected from the mouse lungs using 0.5-1 ml PBS with 1X Halt Protease Inhibitor Cocktail (diluted from 100X; #78429, Thermo Fisher). After collection, the BAL was spun down at 500 g for 5 min before the supernatant was collected and Replicates. Each experiment was performed at least twice, in most cases, by two independent authors.

Blinding. Investigators who assessed, measured and quantified the results were blinded to the intervention.

Genotyping. To confirm the genotypes, tips of the tails of the mice were collected before weaning. Oligomers for PCR amplification were designed to yield products of unique size to identify deleted sequences from C3, C3aR, and Cfb as previously published (62, 63) . PCR reaction for the digested tail samples is as follows:

Step 1 at 94 °C for 4 min, Step 2: 94 °C for 1 min, Step 3: 68 °C for 1 min, Step 4: 72 °C for 1 min, Steps 2-4 repeated for 30 cycles, followed by Step 5 at 72 °C for 5 min, and reaction is concluded at 4 °C until samples are retrieved.

Primers used are listed in Table S3 . The band are visualized with gel electrophoresis using 2-3% agarose (#16500500, Thermo Fisher) gel with SYBR Safe dye (#S33102, Thermo Fisher). 

To assess alveolar-capillary barrier disruption, we used the lung wet-dry ratio and/or BAL protein levels. To assess lung inflammation, we used flow cytometry, BAL cytokine level measurements by ELISA, BAL cell counts, or transcriptional expression of certain inflammatory genes (e.g., Ccl2, Il1β) measured by qRT-PCR. To assess physiological dysfunction, we performed small animal whole body plethysmography. To assess histological evidence of injury, we obtained images at 20x magnification. To assess for epithelial cell death, we measured death using flow cytometry, BAL RAGE levels using an ELISA, or qRT-PCR expression of certain epithelial cell genes (e.g., Scgb1a1, Sftpc, Cdh1).

For the wet-dry ratio, the weight of the "wet" lungs was immediately measured right after euthanasia (#AB54-S, Mettler Toledo, Columbus, OH), and the value obtained was divided by their "dry" weight that was measured after 24 h in an 65 °C oven.

To assess physiological dysfunction, whole body phethysmography was performed. At 24 h postinfection, the mice were anesthetized with the same ketamine/xylazine cocktail as mentioned above and their tracheae were exposed and cannulated with a Surflo 20-gauge catheter (#SR- spun at 500 g for 10 min at 4 °C. After discarding the supernatant, the cells were resuspended in 2 ml ACK Lysing buffer (A10492-01, Gibco) and incubated at RT for 4-7 min, after which they were resuspended in 10 ml of ice-cold 1% BSA in PBS and centrifuged again at 500 g for 10 min at 4° C. 1-2 x 10 6 cells were added to a 96-well plate for staining using the antibodies listed in Table S2 . Data was acquired on an Attune Nxt (14 color) laser (Thermo Scientific) and analyzed using FlowJo v10.8.0 (Becton, Dickinson and Company; Ashland, OR). (Table S4 ). The PCR program was run as follows: an initial pre-incubation step at 95 °C for 3 min followed by 45 cycles of denaturation at 95 °C for 10 seconds, annealing and elongation at 60 °C for 20 seconds, and the fluorescence reading at 72 °C for 1 second. Ct values were read and exported from the LightCycler 480 software, and the commonly used 2(-∆∆Ct) method was used to calculate relative gene expression using Gapdh or Hprt1 as housekeeping gene (65) . Data are shown are adjusted to the housekeeping gene.

Enzyme-linked immunosorbent assays (ELISA). For assessing complement activity in the mouse serum and BAL, we adapted the LPS assay as reported in a prior section. Serum was obtained before and after infection from the same mice; however, BAL was obtained from different mice in the uninfected and infected groups, as the BAL procedure is terminal.

For the BAL protein levels (i.e., BCA assay), fresh or thawed BAL samples were diluted (1:10 to 1:50 in PBS) to fall within the range of the recommended standard curve of the assay, before the total protein level was quantified using Pierce™ BCA Protein Assay Kit (#23227, Thermo Fisher) according to provided protocol.

To assess cytokine levels in the mouse serum and BAL, we used the a multianalyte assay Table S2 ). For beta actin staining, the membrane was stripped and reprobed. The stripping buffer was prepared by mixing 0.7 ml of β -mercaptoethanol, 2 g SDS and 2.5 ml of 1 M Tris-HCl (pH 6.8) in 100 ml of deionized water. The membrane was incubated for 30 min at 55 °C on a shaker in stripping buffer with gentle agitation followed by washing with TBS-T. The membrane was then blocked and detection with antibody was carried out as described above.

Immunostaining. Cells were plated on cover slips in 24 well plates at a seeding density of 10 5 cells/well overnight prior to the experiment. After treating with Pa, cells were fixed by directly adding fixative solution (10% neutral buffered formalin, prepared by mixing 100 ml formaldehyde (37-40%), 900 ml distilled water, sodium phosphate (monobasic) 4 g/L and odium phosphate (dibasic, anhydrous) 6.5 g/L) equal in amount to the medium present in the well. After Immunofluorescence staining of the lungs was performed on paraffin sections. Prior to staining, paraffin embedded lungs tissue sections were deparaffinized using xylene, followed by decreasing concentrations of ethanol. Specifically, slides were dipped in the following sequence for 3 minutes in each solution: 100% xylene, followed by 100% ethanol, 95% ethanol, 75% ethanol, 50% ethanol followed by washing in MilliQ water for hydration and heat-treated with Ag unmasking solution (#H3300, Citrate-Based, Vector Laboratories). Immunostaining was performed with different primary antibodies overnight at 4 °C ( Table S2) . The next day, sections were incubated using Alexa Fluor-conjugated secondary antibodies (Table S2) COMPBIO performs a literature analysis to identify relevant processes and pathways represented by differentially expressed, or otherwise related, biological entities (genes, proteins, miRNA's, or metabolites) or their synonyms using Pubmed abstracts. Knowledge is extracted in an ontology-free manner and maintained in a Persistent Contextual Memory Model (PCMM) that can be aggregated, normalized and computed across from any stored dimension. Conditional probability analysis is utilized to compute the statistical enrichment of contextually associated biological concepts (processes/pathways) over those that occur by random sampling. These related concepts built from the input entities are further clustered into higher-level themes (e.g., biological pathways/processes, cell types and structures, etc.).

Genes, concepts, and theme enrichment is calculated using a multi-component function referred to as the Normalized Enrichment Score (NES) which reflects both the rarity of the concept event associated with an entity list, as well as its degree of overall enrichment. Entity-concept scores above 10.0, 100.0, and 1,000.0 are labeled as moderate, marked, or high in level of enrichment above random. Theme scores are then computed from their constituent entity-concept NES scores. As such, theme enrichment scores above 10,000, 20,000, and 30,000 are identified as having moderated, marked and high levels of entity-concept enrichment, respectively.

Concepts are biologically relevant words or names that have been collected from a multitude of sources of biological language (text) or entities. Within COMPBIO themes, concepts and their relationships are computed in a fully automated fashion. The themes generated by COMPBIO can be annotated with a summary level description of the biological processes and pathways that they represent. This can be achieved either by semi-automated annotation or human assessment.

Semi-automated annotation occurs through a comparison of, up to, the 10 most central concepts of each theme with pathways and processes in common knowledge bases such as GO, Reactome, and several others. The most closely associated entries are computed and presented, with score, for annotation of theme. However, as COMPBIO is not restricted to these knowledge bases in its biological discovery process, some themes can only be annotated with human assessment. In these cases, the process is similar in that the annotation is typically a summary description of the biology described by the most central concepts to the theme. 

Data are presented as scatter plots showing individual data points, and dispersion is shown by mean ± standard deviation. The unpaired t test was used for comparing two groups, assuming equal variance and the ordinary one-way ANOVA test with multiple comparisons testing was used for more than two groups. A p value of < 0.05 was considered significant, although values 

For C3 -/mice, males were used as reported in Figure S1 . For C3aR -/and FB -/mice, there was no effect of sex on the phenotype and hence, animals of both sexes were used.

No specific randomization schema was used. However, to minimize potential confounders, mice were infected and euthanized alternately (e.g., Group 1 mouse 1, Group 2 mouse 1, Group 1 mouse 2, Group 2 mouse 2…)

The person collecting the data (i.e. outcome assessment) for each experiment was blinded to the group allocation.

Listed under the "Outcome Measures" section in the Methods.

Listed under the "Statistical Analysis" section in the Methods.

Species-appropriate details have been provided under "Research subjects or units of investigation" in the Methods section. 9. Experimental Procedures Detailed procedures to facilitate replication, including rationale, have been described under the section "Experimental Procedures" in the Methods section.

All figures have been represented as scatter plots with individual data points, and range is represented as mean ± standard deviation. 

Sequences Product C3 f/f 5`-AGTCAGAAAACTCACGGTCCATCGACTAG-3`, 5`-TGCAAAGTCCCCAACCTCAGACCTAG-3`, 5`-CCTAGCACAAGAGACAGAGACAGCCTAGC-3` 3 primers KI product 259-bp WT product 197-bp Alb-Cre +/-WT 5`-TGCAAACATCACATGCACAC-3`, common 5`-TTGGCCCCTTACCATAACTG-3`, mutant 5`-GAAGCAGAAGCTTAGGAAGATGG-3` 3 primers, KI product 390-bp, WT product 350-bp Scgb1a1-CreER T2+/-5`-GCATTACCGGTCGATGCAACGAGGATGAG -3` 5`-GAGTGAACGAACCTGGTCGAAATCAGTGCG -3` 2 primers, KI product 408-bp Table S4 . Primers used for qRT-PCR of mouse lungs.

Sequences Reference Ccl2

Forward: 5`-AGGTCCCTGTCATGCTTCTG-3` Reverse: 5`-TCTGGACCCATTCCTTCTTG-3`

Ccl7

Il1β

Scgb1a1 Forward 5`-ATCAGAGTCTGGTTATGT-3` Reverse 5`-ATCCACCAGTCTCTTCAG-3`

Sftpc

Forward 5`-GAGAACGGTGGTCAAAGAGC-3` Reverse 5`-GCTGGCTCAAATCAAAGTCC-3`

Gapdh

Hprt1

The individual data points, and bars representing mean ± standard deviation. ns, not significant, * p < 0.05, ** p < 0.01, *** p < 0.001 using unpaired two-tailed t-test. Distribution of data represented as scatter plots showing individual data points, and bars representing mean ± standard deviation. ns, not significant, * p < 0.05, ** p < 0.01 using unpaired two-tailed t-test. representing mean ± standard deviation. ns, not significant, * p < 0.05, ** p < 0.01 using a unpaired two-tailed t-test, except for (B) and (D-H), a one-tailed t-test was used given the null hypothesis was that C3-deficient mice had worse lung injury than WT mice, based on the initial findings.

Pseudomonas aeruginosa (Pa)-induced acute lung injury. individual data points, and bars representing mean ± standard deviation. * p < 0.05, ** p < 0.01, *** p < 0.001 using unpaired two-tailed t-test for two group comparisons, and ordinary one-way analysis of variance (ANOVA) with multiple comparisons testing for more than two groups. 

Integrative Physiology of Pneumonia

Acute Respiratory Distress Syndrome

Acute respiratory distress syndrome

Understanding the Host in the Management of Pneumonia

Emerging roles of the complement system in host-pathogen interactions

Increased Alternative Complement Pathway Function and Improved Survival during Critical Illness

Clinical characteristics and genotype-phenotype correlations in C3 deficiency

Cirrhosis-associated immune dysfunction

Intracellular sensing of complement C3 activates cell autonomous immunity

Complement C3 Drives Autophagy-Dependent Restriction of Cyto-invasive Bacteria

Serum complement after orthotopic transplantation of the human liver

Structure of C3b reveals conformational changes that underlie complement activity

Acute-phase proteins during inflammatory reaction by bacterial infection: Fish-model

Diapedesis-Induced Integrin Signaling via LFA-1 Facilitates Tissue Immunity by Inducing Intrinsic Complement C3 Expression in Immune Cells

Intracellular C3 Protects Human Airway Epithelial Cells from Stress-associated Cell Death

Complement Component C3 Is Highly Expressed in Human Pancreatic Islets and Prevents β Cell Death via ATG16L1 Interaction and Autophagy Regulation

The complement system drives local inflammatory tissue priming by metabolic reprogramming of synovial fibroblasts

SARS-CoV-2 drives JAK1/2-dependent local complement hyperactivation

The complement system in the airway epithelium: An overlooked host defense mechanism and therapeutic target?

A C3(H20) recycling pathway is a component of the intracellular complement system

Sex-hormone-driven innate antibodies protect females and infants against EPEC infection

Complement levels and activity in the normal and LPS-injured lung

Activator-specific requirement of properdin in the initiation and amplification of the alternative pathway complement

Antimouse properdin TSR 5/6 monoclonal antibodies block complement alternative pathwaydependent pathogenesis

Contribution of Adipose-Derived Factor D/Adipsin to Complement Alternative Pathway Activation: Lessons from Lipodystrophy

LungGENS": a web-based tool for mapping singlecell gene expression in the developing lung

Lung Gene Expression Analysis (LGEA): an integrative web portal for comprehensive gene expression data analysis in lung development

Lung Gene Expression Analysis Web Portal Version 3: Lung-at-a-Glance

NHLBI LungMAP Consortium, A census of the lung: CellCards from LungMAP

Maintenance of differentiated murine Clara cells in microdissected airway cultures

Cytokeratin 18 cell death assays as biomarkers for quantification of apoptosis and necrosis in COVID-19: a prospective, observational study

Factor B structure provides insights into activation of the central protease of the complement system

Complement-Mediated Regulation of Metabolism and Basic Cellular Processes

Contextdependent roles of complement in cancer

Complement in metabolic disease: metaflammation and a twoedged sword

Regulation of epithelial cell expressed C3 in the intestine -Relevance for the pathophysiology of inflammatory bowel disease?

Novel insights into the expression pattern of anaphylatoxin receptors in mice and men

Evolution of the complement system: from defense of the single cell to guardian of the intravascular space

Acquired C3 deficiency in patients with alcoholic cirrhosis predisposes to infection and increased mortality

Directional secretomes reflect polarity-specific functions in an in vitro model of human bronchial epithelium

Quantitative proteomics reveals an altered cystic fibrosis in vitro bronchial epithelial secretome

The role of Scgb1a1+ Clara cells in the long-term maintenance and repair of lung airway, but not alveolar, epithelium

Intracellular complement activation sustains T cell homeostasis and mediates effector differentiation

Mitochondrial C5aR1 activity in macrophages controls IL-1β production underlying sterile inflammation

C3aR and C5aR1 act as key regulators of human and mouse β -cell function

Molecular composition of the alveolar lining fluid in the aging lung

Animal models of hospital-acquired pneumonia: current practices and future perspectives

Lung mesenchymal stromal cells influenced by Th2 cytokines mobilize neutrophils and facilitate metastasis by producing complement C3

Complement-containing small extracellular vesicles from adventitial fibroblasts induce proinflammatory and metabolic reprogramming in macrophages

Pseudomonas aeruginosa LasB Subverts Alveolar Macrophage Activity by Interfering With Bacterial Killing Through Downregulation of Innate Immune Defense

Increased complement activation is a distinctive feature of severe SARS-CoV-2 infection

The relationship between complement C3 expression and the MUC5B genotype in pulmonary fibrosis

Complement effectors, C5a and C3a, in cystic fibrosis lung fluid correlate with disease severity

Abrogation of the alternative complement pathway by targeted deletion of murine factor B

A randomized, placebo-controlled trial of complement inhibition in ischemia-reperfusion injury after lung transplantation in human beings

Complement C3 vs C5 inhibition in severe COVID-19: Early clinical findings reveal differential biological efficacy

The ARRIVE guidelines 2.0: updated guidelines for reporting animal research

Genetic disruption of the murine complement C3 promoter region generates deficient mice with extrahepatic expression of C3 mRNA

Cutting edge: targeted disruption of the C3a receptor gene demonstrates a novel protective antiinflammatory role for C3a in endotoxin-shock

Excessive inflammatory response of cystic fibrosis mice to bronchopulmonary infection with Pseudomonas aeruginosa

Complement factor B is the downstream effector of TLRs and plays an important role in a mouse model of severe sepsis

Timing and mechanism of conceptus demise in a complement regulatory membrane protein deficient mouse

Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method

Gene expression profiles compared in environmental and malnutrition enteropathy in Zambian children and adults

Ontology Subcommittee, NHLBI Molecular Atlas of Lung Development Program Consortium, Comprehensive anatomic ontologies for lung development: A comparison of alveolar formation and maturation within mouse and human lung

A Single-Cell Atlas of the Human Healthy Airways

Dissecting the cellular specificity of smoking effects and reconstructing lineages in the human airway epithelium

Single-Cell Transcriptomic Analysis of Human Lung Provides Insights into the Pathobiology of Pulmonary Fibrosis

Single-cell RNA-seq reveals ectopic and aberrant lungresident cell populations in idiopathic pulmonary fibrosis

Single-cell RNA sequencing reveals profibrotic roles of distinct epithelial and mesenchymal lineages in pulmonary fibrosis

Differential Roles of Chemokines CCL2 and CCL7 in Monocytosis and Leukocyte Migration during West Nile Virus Infection

Spleen-derived classical monocytes mediate lung ischemia-reperfusion injury through IL-1β

Epigenetic mechanisms modulate thyroid transcription factor 1-mediated transcription of the surfactant protein B gene

E3 ubiquitin ligase RFWD2 controls lung branching through protein-level regulation of ETV transcription factors

Oropouche virus infection and pathogenesis are restricted by MAVS, IRF-3, IRF-7, and type I interferon signaling pathways in nonmyeloid cells

Secretory phospholipase A2 group IIA modulates insulin sensitivity and metabolism

We thank Drs. Claudia Kemper, Dennis Hourcade, Jeffrey Haspel, Michael Holtzman, Jeffrey Koenitzer and Yi-Chieh Perng for their insights on the work and contribution of reagents. We thank Lynne Mitchell, Kathy Liszewski, Carrie Gierasch and Abigail Pesavento for technical assistance.

Experimental support was also partially provided by the Bursky Center for Human Immunology and Immunotherapy Programs at Washington University Immunomonitoring Laboratory, in support of the Rheumatic Diseases Core Center (NIH WLC6313040077).National 

Littermate controls